| 1. |
Silby MW, Cerde?o-Tárraga AM, Vernikos GS, et al. Genomic and genetic analyses of diversity and plant interactions of Pseudomonas fluorescens. Genome Biol, 2009, 10(5): R51.
|
| 2. |
Liu X, Xiang L, Yin YH, et al. Pneumonia caused by Pseudomonas fluorescens: a case report. BMC Pulm Med, 2021, 21(1): 212.
|
| 3. |
Diaz PI, Hong BY, Frias-Lopez J, et al. Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome. Clin Vaccine Immunol, 2013, 20(6): 920-930.
|
| 4. |
Heirali A, Mckeon S, Purighalla S, et al. Assessment of the microbial constituents of the home environment of individuals with cystic fibrosis (CF) and their association with lower airways infections. PLoS One, 2016, 11(2): e148534.
|
| 5. |
Scales BS, Erb-Downward JR, Huffnagle IM, et al. Comparative genomics of Pseudomonas fluorescens subclade III strains from human lungs. BMC Genomics, 2015, 16: 1032.
|
| 6. |
Dickson RP, Erb-Downward JR, Prescott HC, et al. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol, 2014, 52(10): 3605-3613.
|
| 7. |
Bahrani-Mougeot FK, Paster BJ, Coleman S, et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J Clin Microbiol, 2007, 45(5): 1588-1593.
|
| 8. |
Khabbaz RF, Arnow PM, Highsmith AK, et al. Pseudomonas fluorescens bacteremia from blood transfusion. Am J Med, 1984, 76(1): 62-68.
|
| 9. |
Hsueh PR, Teng LJ, Pan HJ, et al. Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol, 1998, 36(10): 2914-2917.
|
| 10. |
Redding PJ, Mcwalter PW. Pseudomonas fluorescens cross-infection due to contaminated humidifier water. Br Med J, 1980, 281(6235): 275.
|
| 11. |
Dickson RP, Erb-Downward JR, Freeman CM, et al. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One, 2014, 9(5): e97214.
|
| 12. |
Thangkhiew I. Successful treatment with ceftazidime of a Pseudomonas fluorescens chest infection in a myasthenic patient. J Antimicrob Chemother, 1986, 18(3): 428-429.
|
| 13. |
Senbadejo TY, Fagade OE. Antibiotic susceptibility patterns of Pseudomonas species isolated from clinical and environmental samples in Awba Dam, Ibadan. Fountain J Nat Appl Sci, 2017, 6(2): 9-14.
|
1/5
WeChat